Phase of Development: Hit to Lead
Mechanism of Action: Tau Proteostasis, Propagation and Clearance
Compound Type/Modality: Vaccine
Active Vaccine for Tauopathy
Marc Diamond, MD
Professor, UT Southwestern Medical Center (Dallas, TX)
For further information about this program Contact:
-
Project Lead
Drug Discovery drugdiscovery@rainwatercf.org